Death Panels are Not ObamaCare’s Only Killer Provisions

Death Panels are Not ObamaCare’s Only Killer Provisions

January 7th, 2011

Steven Ertelt, LifeNews.com

Never mind the controversy over the so-called death panels in the controversial ObamaCare health care law. One pro-life group says the measure should be repealed because it contains rationing elsewhere.

Although the death panels — the voluntary advanced care planning that pro-life advocates have been concerned about because it could have doctors financially motivated to promote less medical care and lifesaving treatment — have occupied most of the debate, the National Right to Life Committee says other provisions cause concern.

In a new letter to House members that LifeNews.com obtained, NRLC urges a yes vote on the repeal measure the House of representatives is slated to consider next week.

The abortion funding ObamaCare doesn’t satisfactorily prohibit is a central tenet of the pro-repeal letter.

“As enacted, the PPACA contains multiple provisions authorizing federal subsidies for abortion, and additional provisions on which future abortion-expanding regulatory mandates may be based,” the pro-life group tells lawmakers.

But the “Patient Protection and Affordable Care Act” also contains “multiple provisions that will, if fully implemented, result in government-imposed rationing of lifesaving medical care,’ NRLC says:

The department of Health and Human Services (HHS) will be empowered to impose so-called “quality and efficiency” measures on health care providers, based on recommendations by the Independent Payment Advisory Board, which is directed to force private health care spending below the rate of medical inflation. In many cases treatment that a doctor and patient deem needed or advisable to save that patient’s life or preserve or improve the patient’s health but which runs afoul of the imposed standards will be denied, even if the patient wants to pay for it.

The law empowers HHS to prevent older Americans from making up with their own funds for the $555 billion the law cuts from Medicare by refusing to permit senior citizens the choice of private-fee-for-service plans….

Read more.

The FDA’s Death Panels

The FDA’s Death Panels

January 6th, 2011

Gene Koropowski, WorldNetDaily

Former Alaska Gov. Sarah Palin last year created a nationwide furor when she predicted that ObamaCare would lead to the creation of “death panels” that would decide who would receive life-saving treatments – or be allowed to die.

Now Obama’s health policy team stealthily is moving forward with that idea, WND has learned.

And this development has nothing to do with proposed rules that would have called for doctors to have “end of life” discussions annually with senior citizens. Those plans were dropped from ObamaCare because of public outrage, then slipped into administrative rules, then removed once more in just recent days when the public discovered what was going on.

This new development involves Obama’s political appointees at the powerful Food and Drug Administration, who appear to have started making life or death choices for Americans in 2010 using the cost of a therapy, apparently, as a primary criterion for acceptance or rejection, critics have told WND…

“The FDA denies that cost had anything to do with the ultimate decision against approval,” Greg Conko, a senior fellow who tracks the FDA at the Competitive Enterprise Institute, a free-market think tank in Washington, D.C., told WND.

“But many of us fear that FDA may in fact be slowly but covertly moving in that direction,” he said.

According to statistics released by the FDA on its website, new drug approvals declined dramatically last year. Drugs with the potential to treat cancer and other maladies were not approved by Obama’s regulators for mass marketing. FDA approved a mere 21 new drugs for sale in 2010, down from 25 in 2009.

Read more.

ObamaCare: FDA to Cut Off 17,000 Women from Lifesaving Drug

ObamaCare: FDA to Cut Off 17,000 Women from Lifesaving Drug

December 9th, 2010

RedState.com

Obama’s Food and Drug Administration (FDA) is due to take up the case   of Avastin, a cancer drug that successfully treats some 17,000 women   annually. With a coming December 17 decision, the FDA seems poised to   take this drug away from these patients quite despite the fact that   their doctors find the drug effective.

The most dangerous period of time in Washington D.C. is that time we   call the lame duck session (I call it the zombie congress; dead men   walking). It is that time when those elected officials that are about to   be ingloriously shipped off home for the last time due to losing   election results make a mad scramble to grab for as much as they can   get.

In the case of regulatory agencies like the FDA the lame duck session   is not treated in exactly the same manner, but it is sure that when   congress is about to have its majority party change over with the   president’s party on the losing side of the switch, regulatory agencies   often try to push through favored policies before the new congress is   seated and before that new congress is in a position to put any pressure   on those agencies to prevent them from pushing the president’s agenda.

Read more.